XOBIOME
LIVE

Serial Number

79389665

Owner

Biomecentric Pty Ltd

Attorney

C. Blair Barbieri

Filing Date

Dec 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

XOBIOME Trademark

Serial Number: 79389665 • Registration: 7789465

XOBIOME is a trademark filed by Biomecentric Pty Ltd on December 28, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Biomecentric Pty Ltd (3 trademarks)

27 Expansion St

Entity Type: 82

Trademark Details

Filing Date

December 28, 2023

Registration Date

May 13, 2025

Published for Opposition

March 25, 2025

Goods & Services

Bacteria, namely, cultures of microorganisms other than for medical or veterinary purposes; bacterial and bacteriological preparations, namely, cultures of microorganisms other than for medical and veterinary use; bacterial substances, namely, cultures of microorganisms for industrial and scientific use, namely, cellular extracts, extracellular vesicles and exosomes; bacteriological cultures, namely, cultures of microorganisms other than for medical and veterinary use, namely, for addition to cosmetics, skincare products, hair care products, food and beverage, and pharmaceutical products; cultures of microorganisms other than for medical or veterinary purposes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; enzyme preparations for industrial purposes, including preparations for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; probiotic bacterial formulations, namely, cultures of microorganisms other than for medical use; starter media being cell culture media for medical research use and enzymes for industrial purposes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; plant and cellular extracts being extracellular vesicles, namely, exosomes for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; extracellular vesicles, namely, exosomes being cellular plant extracts for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations; and raw materials being proteins and raw natural resins, and semi-finished products being chemical resins, namely, unprocessed synthetic resins and active chemical ingredients, all for use in the manufacture of cosmetics, skincare products, hair care products, dietary supplements, nutritional food and beverage supplements, pharmaceutical preparations, homeopathic preparations and herbal preparations

Bacteria being cultures of microorganisms for medical or veterinary purposes; bacterial cultures being cultures of microorganisms for medical or veterinary use; bacterial preparations and products, namely, cultures of microorganisms for medical and veterinary use; biological agents being bacterial preparations, namely, cultures of microorganisms for medical purposes and for use as fungicides; biological preparations for medical, pharmaceutical, veterinary and diagnostic purposes, namely, cultures of microorganisms; nutritionally fortified beverages for medical purposes, namely, beverages containing added minerals, added trace elements and added vitamins; chemical and biochemical preparations being diagnostic reagents for medical diagnostic use; therapeutic preparations, namely, diagnostic agents, biological products in the nature of cultures of microorganisms and skin creams being for medical use; chemical products for use in detection or identification of bacteria, namely, diagnostic reagents for medical or veterinary use; cultures for medical, pharmaceutical or veterinary use, namely, cultures of microorganisms; cultures of microorganisms for medical or veterinary use for use in dietary supplements, nutritional food and beverage supplements and pharmaceutical preparations; cell culture media for medical or veterinary use; pharmaceutical and veterinary preparations for skin care; dietetic nutrients and substances for medical and veterinary use, namely, dietary supplements; dietary supplements, namely, nutritional supplements for animals and infants; dietary food preparations for medical use being medical food, namely, dietetic foods adapted for medical use; dietary food and protein supplements, namely, supplements with a cosmetic effect; diagnostic preparations for medical use and for pharmaceutical use, namely, diagnostic materials being diagnostic reagents and reagents; food supplements; herbal nutritionally fortified beverages for medicinal purposes; probiotic bacterial preparations, namely, preparations in the nature of food supplements for human consumption; probiotic bacterial formulations being dietary supplements for medical and veterinary use; medicated food supplements and nutritionally fortified beverages; medicated preparations for use as supplements for food and animal feedstuffs; medicinal nutritionally fortified beverages; nutritional supplements for human consumption and animal feed; and pharmaceutical preparations, namely, for use in treating skin and gastrointestinal disorders

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 9, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 9, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 9, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 9, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 9, 2026 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 5, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2026 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 25, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 6, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 6, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 13, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 14, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 14, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 13, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 13, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 3, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 3, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 3, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 3, 2025 CNEA
ASSIGNED TO EXAMINER
Feb 25, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2025 TROA
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
REFUSAL PROCESSED BY IB
Aug 31, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2024 REPR